Kirkland Advises Butterfly on Sale of Stake in MaryRuth Organics

Kirkland & Ellis advised private equity firm Butterfly on the sale of a majority of its stake in vitamins, minerals and supplements brand MaryRuth Organics, LLC. The transaction was announced August 15, 2024. Since acquiring a stake in MaryRuth's in August 2021, Butterfly has helped the Company nearly triple in size and quadruple its profitability. Under the new capital structure, MaryRuth Ghiyam and her family will retain a significant majority ownership of the business. To support MaryRuth’s growth and as part of the transaction, global alternative investment firm King Street will provide financing to the company. Butterfly will remain an active investor in the business and retain representation on the Board of Directors.

Read the transaction press release

The Kirkland team was led by corporate partners Ravi Agarwal and Sean Rodgers; debt finance partners Melissa Hutson and Tim Hughes; tax partner Ben Schreiner; and executive compensation partner Scott Price.